<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727621</url>
  </required_header>
  <id_info>
    <org_study_id>IRB000087801</org_study_id>
    <nct_id>NCT02727621</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Sedation and Cardiopulmonary Bypass</brief_title>
  <official_title>Dexmedetomidine Based Versus Propofol Based Anesthesia in Patients Undergoing Coronary Revascularization: a Randomized, Double-blind Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine is a unique sedative anesthetic agent that allows accurate control of the
      depth of sedation and provides analgesia, cardio protection, renal protection, and
      neuroprotection without causing respiratory depression. It is an alpha 2-adrenoreceptor
      agonist that modulates the release of catecholamines from the central and autonomic nervous
      systems. When patients sedated by dexmedetomidine are allowed to become responsive, they are
      calm and cooperative (1). No other sedative agent has this feature, and sedated patients
      frequently awaken in a confused state. Investigators are conducting this study project to
      compare between dexmedetomidine based and propofol based anesthetic techniques with regard to
      hemodynamic changes, stress hormone release as well as cytokines in patients undergoing CPB
      for coronary revascularization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      100 patients undergoing elective CPB for coronary revascularization surgery. On the morning
      of operation the patients were randomized to receive one of two anesthetic techniques
      dependent on the type of sedation used. Standard anesthetic technique will be used for all
      patients except for using dexmedetomidine sedation in one group and propofol sedation in the
      other group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac index</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>cardiac index measured in L/min/m2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>heart rate measured in beat/min.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>mean arterial blood pressure measured in mm.Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central venous pressure</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>central venous pressure measured in mm.Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulmonary capillary wedge pressure</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>pulmonary capillary wedge pressure measured in mm.Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean pulmonary artery pressure</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>mean pulmonary artery pressure measure in mm.Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systemic vascular resistance index</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>systemic vascular resistance index measured in dyn.sec/cm5/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulmonary vascular resistance index</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>pulmonary vascular resistance index measured in dyn.sec/cm5/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke volume index</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>stroke volume index measured in ml/m2/beat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular stroke work index</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>left ventricular stroke work index measured in gm/m2/beat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>within intraoperative period</time_frame>
    <description>cardiac output measured in L/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inotrope score</measure>
    <time_frame>1st 24 hours</time_frame>
    <description>appropriate score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>1st week</time_frame>
    <description>duration of mechanical ventilation measured in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation score</measure>
    <time_frame>1st 24 hours</time_frame>
    <description>appropriate score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Coronary Artery Bypass Grafting</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Anesthesia will be maintained with continuous infusion of dexmedetomidine 0.5-0.7 µg/kg/h in addition to sevoflurane supplementation as required, to maintain arterial blood pressure and heart rate within 20% of preoperative values. Muscle relaxation will be maintained with continuous rocuronium infusion 0.6 mg/kg/h.</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>Anesthesia will be maintained with continuous infusion of propofol 50-100 µg/kg/min in addition to sevoflurane supplementation as required, to maintain arterial blood pressure and heart rate within 20% of preoperative values. Muscle relaxation will be maintained with continuous rocuronium infusion 0.6 mg/kg/h.</description>
    <arm_group_label>Propofol group</arm_group_label>
    <other_name>diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for elective coronary revascularization surgery with
             cardiopulmonary bypass

        Exclusion Criteria:

          -  Severely impaired left ventricular function (ejection fraction &lt;40%)

          -  Valvular heart disease

          -  Low cardiac output syndrome

          -  Uncontrolled rapid atrial fibrillation

          -  On plavix less than one week

          -  Severe systemic non-cardiac disease

          -  Infectious disease

          -  Poorly controlled diabetes mellitus

          -  patients on corticosteroids or other immunosuppressive treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sayed Abd-Elshafy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate professor, anesthesia and critical care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2016</study_first_submitted>
  <study_first_submitted_qc>April 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>September 25, 2016</last_update_submitted>
  <last_update_submitted_qc>September 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Sayed Kaoud Abd-Elshafy</investigator_full_name>
    <investigator_title>Associate Professor (Anesthesiology and Critical Care)- College of Medicine-Assiut University</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Cardiac</keyword>
  <keyword>Coronary Artery Bypass Grapht</keyword>
  <keyword>Sedation</keyword>
  <keyword>Propofol</keyword>
  <keyword>Intravenous Anesthetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

